tri-magnesio citrato, Ph.Eur., USP, anidro, 100g, involucro di plastica.

3-(2-Aminoethoxy)pyridine, 95.0%, 1g

Methyl 2-(2-iodo-3,4-dimethoxyphenyl)acetate, 97%, 250mg

4-(2-chloro-5-nitrobenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Idarubicin Hydrochloride, 98%, 1mg

4-amino-5-pyridin-4-yl-4H-1,2,4-triazole-3-thiol, 99.0%, 2.5g

Acetamide, N-(5,6-dihydro-6-oxo-2-phenanthridinyl)-2-(dimethylamino)-, 98%, 5mg

Ciclopentano, min 95%, per sintesi, 1L, confezione in vetro

(6-(Trifluoromethyl)pyridazin-3-yl)methanol, 95%, 100mg

tert-butyl 5'-bromo-2'-oxo-1',2'-dihydrospiro[piperidine-4,3'-pyrrolo[2,3-b]pyridine]-1-carboxylate, 95.0%, 100mg

3-FLUORO-4-IODOPYRIDIN-2(1H)-ONE, 95%, 250mg

N-(4-Phenoxy-phenyl)-acetamide, 95.0%, 1g

6-(4-Bromo-phenyl)-3H-thieno[3,2-d]pyrimidin-4-one, 1g